Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Aldeyra Therapeutics, Inc. (ALDX) had Stock-Based Compensation of $2.42M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.77M |
|
-- |
|
-- |
|
$10.17M |
|
$-10.17M |
|
$0.40M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-10.17M |
|
$-10.54M |
|
60.05M |
|
60.05M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$84.56M |
|
-- |
|
$0.40M |
|
$84.96M |
|
$29.53M |
|
-- |
|
$0.14M |
|
$29.67M |
|
$55.29M |
|
$55.29M |
|
$55.29M |
|
60.05M |
|
| Cash Flow Statement Financials | |
$-21.02M |
|
$6.74M |
|
$1.00M |
|
$54.53M |
|
$41.24M |
|
$-13.29M |
|
|
Stock-Based Compensation |
$2.42M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.67% |
|
-17.67% |
|
-11.50% |
|
-17.67% |
|
$0.92 |
|
$-0.35 |
|
$-0.35 |
|